# Insulin receptor expression and its association with hyperinsulinemia in triple negative breast cancer

**Authors:** Alexis J Engel, Krupa Samuel, Ilana R Bass, Sylvia Lin, Irini Markella Antoniou, Radhi Yagnik, Elisa Port, Sheldon M Feldman, Neil B Friedman, Susan K Boolbol, Brigid Killelea, Melissa Pilewskie, Lydia Choi, Christopher A Galifi, Teresa L Wood, Nathan G Kase, Derek LeRoith, Nina A Bickell, Emily J Gallagher

PMC · DOI: 10.1210/jendso/bvag041 · Journal of the Endocrine Society · 2026-02-17

## TL;DR

This study explores how insulin receptor expression in triple negative breast cancer relates to hyperinsulinemia and other factors in Black and White women.

## Contribution

The study provides new insights into racial and metabolic associations with insulin receptor expression in TNBC.

## Key findings

- 63% of TNBC cases showed positive insulin receptor staining.
- Higher fasting insulin levels were associated with insulin receptor expression in TNBC.
- Black women had more frequent insulin receptor staining compared to White women.

## Abstract

Hyperinsulinemia and tumor insulin receptor (IR) expression have been associated with triple negative breast cancer (TNBC) progression in preclinical models. We aimed to evaluate the expression of the IR, IGF-1 receptor (IGF-1R), and associated signaling protein expression in TNBC and their correlations with demographic and metabolic parameters in a population of women with TNBC.

We identified cases of TNBC from our multi-institutional, cross-sectional study of self-identified Black and White women with newly diagnosed breast cancer. Survey, anthropometric, screening behavior, laboratory, and tumor pathology reports were collected, along with formalin-fixed paraffin embedded tumor samples. We performed immunohistochemistry (IHC) analysis and quantified the expression of IR, IGF-1R, phosphorylated Erk1/2 (pErk1/2), and FOXO3a. Clinical information was correlated with IHC scoring.

There were 93 TNBC cases. IHC staining and quantification found that 63% of TNBC cases stained positive for IR, 73% for IGF-1R, 67% for FOXO3a, and 43% for pErk1/2. Positive IR staining was more prevalent in Black women than White women (P = .003) and was associated with body mass index and fasting insulin on univariate analysis but was not significantly associated with age. On multivariate analysis, IR expression was associated with fasting insulin but not race. IGF-1R, FOXO3a, and pErk1/2 staining were not associated with any of these factors.

Tumor IR expression was associated with higher fasting insulin, and higher fasting insulin was more prevalent among Black women. Further studies are needed to determine the importance of hyperinsulinemia and tumor IR expression in the development of TNBC.

## Linked entities

- **Genes:** Insr (insulin receptor) [NCBI Gene 16337], IGF1R (insulin like growth factor 1 receptor) [NCBI Gene 3480], PERK12 (Protein kinase superfamily protein) [NCBI Gene 838963], FOXO3 (forkhead box O3) [NCBI Gene 2309]
- **Diseases:** triple negative breast cancer (MONDO:0005494)

## Full-text entities

- **Genes:** IGF1R (insulin like growth factor 1 receptor) [NCBI Gene 3480] {aka CD221, IGFIR, IGFR, JTK13}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, FOXO3 (forkhead box O3) [NCBI Gene 2309] {aka AF6q21, FKHRL1, FKHRL1P2, FOXO2, FOXO3A}, INSR (insulin receptor) [NCBI Gene 3643] {aka CD220, HHF5}
- **Diseases:** breast cancer (MESH:D001943), Tumor (MESH:D009369), TNBC (MESH:D064726), Hyperinsulinemia (MESH:D006946)
- **Chemicals:** paraffin (MESH:D010232), formalin (MESH:D005557)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13043147/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13043147/full.md

## References

44 references — full list in the complete paper: https://tomesphere.com/paper/PMC13043147/full.md

---
Source: https://tomesphere.com/paper/PMC13043147